Switch theme
Sign up to access all valuation multiples
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 28%, China about 16% and the rest of the world about 19%.
1991
17.3K+
LTM Revenue $3.9B
LTM EBITDA $1.2B
$26.0B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Mettler Toledo has a last 12-month revenue (LTM) of $3.9B and a last 12-month EBITDA of $1.2B.
In the most recent fiscal year, Mettler Toledo achieved revenue of $3.9B and an EBITDA of $1.2B.
Mettler Toledo expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Mettler Toledo valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $3.9B | XXX | $3.9B | XXX | XXX | XXX |
| Gross Profit | $2.4B | XXX | $2.3B | XXX | XXX | XXX |
| Gross Margin | 62% | XXX | 60% | XXX | XXX | XXX |
| EBITDA | $1.2B | XXX | $1.2B | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBIT | $1.2B | XXX | $1.1B | XXX | XXX | XXX |
| EBIT Margin | 30% | XXX | 29% | XXX | XXX | XXX |
| Net Profit | $858M | XXX | $863M | XXX | XXX | XXX |
| Net Margin | 22% | XXX | 22% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $2.0B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Mettler Toledo's stock price is $1156.
Mettler Toledo has current market cap of $24.0B, and EV of $26.0B.
See Mettler Toledo trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $26.0B | $24.0B | XXX | XXX | XXX | XXX | $41.28 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Mettler Toledo has market cap of $24.0B and EV of $26.0B.
Mettler Toledo's trades at 6.7x EV/Revenue multiple, and 21.1x EV/EBITDA.
Equity research analysts estimate Mettler Toledo's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Mettler Toledo has a P/E ratio of 28.0x.
See valuation multiples for Mettler Toledo and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24.0B | XXX | $24.0B | XXX | XXX | XXX |
| EV (current) | $26.0B | XXX | $26.0B | XXX | XXX | XXX |
| EV/Revenue | 6.7x | XXX | 6.7x | XXX | XXX | XXX |
| EV/EBITDA | 20.9x | XXX | 21.1x | XXX | XXX | XXX |
| EV/EBIT | 22.1x | XXX | 23.1x | XXX | XXX | XXX |
| EV/Gross Profit | 10.9x | XXX | n/a | XXX | XXX | XXX |
| P/E | 28.0x | XXX | 27.8x | XXX | XXX | XXX |
| EV/FCF | 29.0x | XXX | 30.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialMettler Toledo's last 12 month revenue growth is 3%
Mettler Toledo's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Mettler Toledo's rule of 40 is 34% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Mettler Toledo's rule of X is 39% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Mettler Toledo and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 32% | XXX | 32% | XXX | XXX | XXX |
| EBITDA Growth | 2% | XXX | 2% | XXX | XXX | XXX |
| Rule of 40 | 34% | XXX | 35% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 39% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 5% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 31% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Australian Clinical Labs | XXX | XXX | XXX | XXX | XXX | XXX |
| Healius | XXX | XXX | XXX | XXX | XXX | XXX |
| Integral Diagnostics | XXX | XXX | XXX | XXX | XXX | XXX |
| Sonic Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Bangkok Dusit Medical Services | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Mettler Toledo acquired XXX companies to date.
Last acquisition by Mettler Toledo was XXXXXXXX, XXXXX XXXXX XXXXXX . Mettler Toledo acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Mettler Toledo founded? | Mettler Toledo was founded in 1991. |
| Where is Mettler Toledo headquartered? | Mettler Toledo is headquartered in United States of America. |
| How many employees does Mettler Toledo have? | As of today, Mettler Toledo has 17.3K+ employees. |
| Who is the CEO of Mettler Toledo? | Mettler Toledo's CEO is Mr. Patrick Kaltenbach. |
| Is Mettler Toledo publicy listed? | Yes, Mettler Toledo is a public company listed on NYS. |
| What is the stock symbol of Mettler Toledo? | Mettler Toledo trades under MTD ticker. |
| When did Mettler Toledo go public? | Mettler Toledo went public in 1997. |
| Who are competitors of Mettler Toledo? | Similar companies to Mettler Toledo include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare. |
| What is the current market cap of Mettler Toledo? | Mettler Toledo's current market cap is $24.0B |
| What is the current revenue of Mettler Toledo? | Mettler Toledo's last 12 months revenue is $3.9B. |
| What is the current revenue growth of Mettler Toledo? | Mettler Toledo revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Mettler Toledo? | Current revenue multiple of Mettler Toledo is 6.7x. |
| Is Mettler Toledo profitable? | Yes, Mettler Toledo is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Mettler Toledo? | Mettler Toledo's last 12 months EBITDA is $1.2B. |
| What is Mettler Toledo's EBITDA margin? | Mettler Toledo's last 12 months EBITDA margin is 32%. |
| What is the current EV/EBITDA multiple of Mettler Toledo? | Current EBITDA multiple of Mettler Toledo is 20.9x. |
| What is the current FCF of Mettler Toledo? | Mettler Toledo's last 12 months FCF is $898M. |
| What is Mettler Toledo's FCF margin? | Mettler Toledo's last 12 months FCF margin is 23%. |
| What is the current EV/FCF multiple of Mettler Toledo? | Current FCF multiple of Mettler Toledo is 29.0x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
